retatrutide phase 2 trial obesity nejm 2023 triple agonist vs. Ozempic: The That May Change Everything., Semaglutide hits one receptor. Retatrutide hits three., That difference may be the biggest leap in metabolic medicine since , Another Promising Medication (Retatrutide) for

(pls excuse the duplicate posting in the imeglimin thread) Claude seems to think these would be synergestic, and in my opinion, Reta + SGLT-2 + imeglimin is probably a much more beneficial stack than whatever crazy & expensive things other biohackers are carrying out (e.g

F.HoebelB

The usual narrative from Longo, Fontana, and even from the vegan community is that elevated levels of IGF-1 trigger proliferative signals, so in some conditions it may be favorable to the proliferation of cancer cells, which are avidly searching nutrients like glucose and growth factors to multiply anomalously

Liraglutide in apoE / mice reduced body weight as well as suppressed macrophage-driven atherosclerosis

Development of glutathione-deficient embryos in Arabidopsis is influenced by the maternal level of glutathione